Commentary · 21 Feb 2026
Conference abstractPublished 3 Nov 2015
Vasoactive peptide urotensin II as a new chemokine exhibiting migration/adhesion mesenchymal properties during glioma development: New therapeutic target
1Inserm U982, DC2N, IRIB, UniversitÃ?© de Rouen, 76821 Mont-Saint-Aignan. 2EA 4108, Laboratory of informatics LITHIS, Center H. Becquerel, Rouen
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
One of the most potent vasoactive peptides, urotensin II (UII), is involved in endothelial cell proliferation and migration, by activating a G protein-coupled receptor, the UT receptor. We showed a high expression of UII/UT in human glioblastomas (GBM), gliosarcoma and a number of carcinoma compared to oligodendrogliomas or health brain tissue. In GBM, a strong staining in vascular and peri-necrotic area and a systematic co-expression of UII/UT with SDF1Ã?±/CXCR4 were observed. In glioma and endothelial cells, gradient concentrations of UII induced chemoattracting migratory effects and tube formation. This effect was blocked by UT antagonists and mainly involved the G13/Rho/ROCK pathway while partially requiring Gi/o/PI3K components. In contrast, we observed that homogeneous concentrations of UII blocked cell motility and stimulated cell-matrix adhesions through a UT/Gi/o signaling cascade, partially involving PI3K. Finally, homogeneous concentration of UII allowed translocation of GÃ?±13 to the UT receptor at the plasma membrane and increased actin stress fibers, lamellipodia formation and vinculin-stained focal adhesions. UII also induced relocalization of UT pre-coupled to GÃ?±i in filipodia and initiated integrin-stained focal points. In C57/Bl6 mice, UT agonists stimulated matrigel sponge invasion by macrophages, endothelial and smooth muscle cells, stressing the chemokine and pro-neoangiogenic properties of UII in vivo. In heterotopic GBM xenografted in Nude mice, intratumoral injection of UII accelerated tumor growth and necrosis, and stimulated neo-angiogenesis through metalloprotease activation. UT Antagonists/biased ligands inhibited tumor growth, neo-angiogenesis and prolonged mice survival. Micro-SPECT imaging showed increased integrin expression, correlated with large necrotic area in tumors treated with UII. Thus, UII promotes the recruitment of pro-angiogenic cells, induces cell adhesions and stimulates necrosis and neo-angiogenesis involved in glioblastoma growth. The specific blockage of UT signalings by using antagonists or biased ligands would constitute a new route for the treatment of GBM. Supported by the University of Rouen, Inserm, Haute-Normandie Region, GÃ?©fluc and the Perene network.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Lecointre”
- BylineArticles whose byline prints “V LeJoncour”
- BylineArticles whose byline prints “P-O Guichet”
- BylineArticles whose byline prints “J E Joubert”
- BylineArticles whose byline prints “N Perzo”
- BylineArticles whose byline prints “P Véra”
- BylineArticles whose byline prints “P Bohn”
- BylineArticles whose byline prints “F Morin”
